Parallel Advisors’s Immunovant IMVT Stock Holding History

Parallel Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.65K	Hold	108	–	–	﹤0.01%	3473
2026 Q2	$4.16K	Hold	108	–	–	﹤0.01%	3282
2026 Q1	$2.68K	Hold	108	–	–	﹤0.01%	3275
2025 Q4	$2.74K	Buy	108 +26	+32%	+$580	﹤0.01%	3045
2025 Q3	$1.32K	Sell	82 -1,224	-94%	-$19.8K	﹤0.01%	3150
2025 Q2	$20.9K	Buy	1,306 +1,299	+18,557%	+$19.6K	﹤0.01%	2171
2025 Q1	$120	Sell	7 -31	-82%	-$648	﹤0.01%	3429
2024 Q4	$941	Buy	+38	New	+$1.08K	﹤0.01%	3121
2023 Q2	–	Sell	-24	Closed	-$372	–	3446
2023 Q1	$372	Hold	24	–	–	﹤0.01%	3193
2022 Q4	$426	Hold	24	–	–	﹤0.01%	3062
2022 Q3	$0	Buy	+24	New	+$117	﹤0.01%	3314
2022 Q1	–	Sell	-382	Closed	-$3K	–	3105
2021 Q4	$3K	Buy	+382	New	+$3.15K	﹤0.01%	2579
2021 Q3	–	Sell	-14,262	Closed	-$151K	–	3160
2021 Q2	$151K	Hold	14,262	–	–	0.01%	803
2021 Q1	$229K	Buy	+14,262	New	+$376K	0.01%	593

Other funds holding IMVT

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Arizona State Retirement System Phoenix, Arizona $20.3B AUM 36.55% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Parallel Advisors's IMVT Position: Q3 2026 in Review

Parallel Advisors held its Immunovant (IMVT) position steady in Q3 2026 at 108 shares worth $3.65K. The position accounts for ﹤0.01% of the portfolio, ranked #3473.

Parallel Advisors first reported a position in IMVT in Q1 2021 and has held it in 14 quarters since. The position peaked at $229K in Q1 2021. 46 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

Parallel Advisors held 108 shares of Immunovant worth $3.65K as of Q3 2026.
Parallel Advisors left its Immunovant share count unchanged in Q3 2026.
Immunovant made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3473 holding.
Parallel Advisors first reported a position in Immunovant in Q1 2021 and has held it in 14 quarters since.
Parallel Advisors's Immunovant position peaked at $229K in Q1 2021.
46 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.